Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126714 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Macarena Artigas-Arias und 2 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Doctorado en Ciencias Mención Biología Celular y Molecular Aplicada, Universidad de La Frontera, Temuco 4811230, Chile. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Muscular Atrophy, Muscle, Skeletal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo and Universidad de La Frontera, Universidad de La Frontera, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Breast cancer is the type of cancer with the highest prevalence in women worldwide. Skeletal muscle atrophy is an important prognostic factor in women diagnosed with breast cancer. This atrophy stems from disrupted skeletal muscle homeostasis, triggered by diminished anabolic signalling and heightened inflammatory conditions, culminating in an upregulation of skeletal muscle proteolysis gene expression. The importance of delving into research on modulators of skeletal muscle atrophy, such as microRNAs (miRNAs), which play a crucial role in regulating cellular signalling pathways involved in skeletal muscle protein synthesis and degradation, has been recognised. This holds true for conditions of homeostasis as well as pathologies like cancer. However, the determination of specific miRNAs that modulate skeletal muscle atrophy in breast cancer conditions has not yet been explored. In this narrative review, we aim to identify miRNAs that could directly or indirectly influence skeletal muscle atrophy in breast cancer models to gain an updated perspective on potential therapeutic targets that could be modulated through resistance exercise training, aiming to mitigate the loss of skeletal muscle mass in breast cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Doctorado en Ciencias Mención Biología Celular y Molecular Aplicada, Universidad de La Frontera, Temuco 4811230, Chile.
- Interdisciplinary Post-graduate Program in Health Sciences, Universidade Cruzeiro do Sul, São Paulo 01506-000, Brazil.
- Departamento de Ciencias de la Rehabilitación, Facultad de Medicina, Universidad de La Frontera, Temuco 4811230, Chile.
ORCID-Profile: Rui Curi, Gabriel Nasri Marzuca-Nassr
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo and Universidad de La Frontera
- Universidad de La Frontera
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Research and Development Agency (ANID)
Zitieren
APA
Artigas-Arias, M., Curi, R., & Marzuca-Nassr, G. N. (2024). Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126714
Vancouver
Artigas-Arias M, Curi R, Marzuca-Nassr GN. Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126714
BibTeX
@article{ArtigasArias2024,
author = {Artigas-Arias, Macarena and Curi, Rui and Marzuca-Nassr, Gabriel Nasri},
title = {Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126714}
}
EUVIMED